The Indian Pharmacopoeia Commission (IPC) issued a drug safety alert in December 2023 advising healthcare professionals and patients to monitor adverse reactions to ‘Meftal’, which has _______ properties
1
antihistamine
2
antipyretic
3
antacid
4
antipruritic